Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.

British journal of cancer - 22 Aug 2005

Lindmark F, Zheng S L, Wiklund F, Bälter K A, Sun J, Chang B, Hedelin M, Clark J, Johansson J-E, Meyers D A, Adami H-O, Isaacs W, Grönberg H, Xu J

Abstract excerpt

IL1-RN is an important anti-inflammatory cytokine that modulate the inflammation response by binding to IL1 receptors, and as a consequence inhibits the action of proinflammatory cytokines IL1alpha and IL1beta. In this study, we hypothesise that sequence variants in the IL1-RN gene are associated with prostate cancer risk. The study population, a population-based case-control study in Sweden, consisted of 1383...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Interleukin 1 Receptor Antagonist Protein

Share to Odds Ratio

Share to Prostatic Neoplasms

Share to Sialoglycoproteins

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 16106254
DOI: 10.1038/sj.bjc.6602729
PMCID: PMC2361575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.PMID 16106254Read ↗

Genetic polymorphism of interleukin-1A (IL-1A), IL-1B, and IL-1 receptor antagonist (IL-1RN) and prostate cancer risk.Semantic proximity Read ↗

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.Semantic proximity Read ↗

Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based studySemantic proximity Read ↗

A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.Semantic proximity Read ↗

Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer.Semantic proximity Read ↗

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.Semantic proximity Read ↗

Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial.Semantic proximity Read ↗

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.Semantic proximity Read ↗

Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer.Semantic proximity Read ↗

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.Semantic proximity Read ↗

Genetic variability in inflammation pathways and prostate cancer risk.Semantic proximity Read ↗

Discrimination of Patients with Prostate Cancer from Healthy Persons Using a Set of Single Nucleotide Polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.